Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine if the presence of Mycoplasma hominis bacteria is associated with Bacterial vaginosis (BV), non-gonococcal urethritis (NGU) or vaginitis in patients attending sexual health clinic. Patients were participants of the MYCO WELL D-ONE study. Ethics for this follow-on pathway-to-portfolio study (IRAS:253889) is now approved by NRES and HCRW. The important primary aim of this study is to determine if Mycoplasma hominis (M.hominis) is associated with BV, NGU and vaginitis in the genitourinary system of patients or if they are bacterial commensals. This is important proof of concept work. The secondary aim for this research is to determine if there are clinical and social parameters that are associated with Mycoplasma infection. Preliminary analysis of 100 patients yielded pilot data suggesting M.hominis is strongly associated with BV, NGU and vaginitis. We aim to consolidate these findings by expansion to 1000 patients from our completed MYCOWELL D-ONE study.


Clinical Trial Description

The clinical study site is The Department of Sexual Health, Dewi Sant Hospital, Cwm Taf University Health Board. This study will retrospectively examine the clinical notes of consented participants (IRAS project ID:253889) in the MYCO WELL D-ONE study (IRAS project ID:230693). Notes will be identified by the sexual health clinic number. The clinic proforma records the following parameters: 1. Gender the patient identifies with 2. Age of the patient when the MYCO WELL D-ONE study sample collected 3. Symptoms and signs that were recorded in the patient notes e.g. BV/NGU 4. Previous sexually transmitted infections diagnosed 5. Drug history 6. Treatments the patient received 7. Sexual history e.g. type of sexual activity On completion, he parameters associated with positive M.hominis result; bacteria load quantification/antimicrobial resistance) and statistical analysis will be examined as below. I Statistical analysis This will be performed on anonymised data. The primary outcome measure of this study is to determine if M.hominis is associated with BV, NGU and vaginitis in the genitourinary system of patients or if it is a bacterial commensal. The secondary outcome for this research is to determine if there are clinical and social parameters that are associated with M.hominis infection. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05186792
Study type Observational
Source Cwm Taf University Health Board (NHS)
Contact
Status Completed
Phase
Start date April 5, 2019
Completion date October 5, 2019

See also
  Status Clinical Trial Phase
Completed NCT04182230 - UROGEN WELL D-ONE : Evaluation of a Novel Diagnostic for Sexually Transmitted Bacterial Infections
Completed NCT02552914 - Evaluation of the Use of the Colli-Pee Device to Collect First-void Urine for Molecular Detection of STIs
Recruiting NCT05391035 - The Antibiotic Guardian Study- Clinical Evaluation of a Novel, Rapid Diagnostic for Gonorrhoea and Mycoplasma Infections.
Terminated NCT03684668 - Psychoeduc Interv. Through Meta-universes on Condom's Use Self - Efficacy and Sexual Behavior in Students of UAChile N/A
Completed NCT04491422 - Same-Day PrEP Initiation and Sexual Health for Transgender Women N/A
Active, not recruiting NCT04036396 - Prevention Support for People Leaving Jail N/A
Completed NCT04036318 - Evaluation of Presumptive Periodic Treatment (PPT) of Sexually Transmitted Infections (STIs)
Completed NCT05307991 - Integrating Enhanced HIV PrEP Into a STI Clinic in Lilongwe
Active, not recruiting NCT04664998 - Alignment of PrEP Use With HIV Risk in Young Women and Men Phase 4
Recruiting NCT04552171 - Game Plan: Efficacy of a Brief, Web-based Intervention on Alcohol Use and Sexually-transmitted Infections N/A
Not yet recruiting NCT06188442 - Superiority of On-demand PrEP Versus PEP on Using Doxycycline for Preventing STI in MSM Phase 4
Not yet recruiting NCT04244994 - Self-taken Penile Meatal Swabs for Chlamydia, Gonorrhoea and Mycoplasma Genitalium Detection N/A